Compare Logitech International SA (LOGI) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs Novavax Inc — how do they compare? Logitech International SA trades at $101.7 (market cap $14.65B), while Novavax Inc trades at $8.08 (market cap $1.30B). The key difference: Logitech International SA is far larger — about 11.3× Novavax Inc's market cap, and Logitech International SA pays a 1.67% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| LOGI | NVAX | |
|---|---|---|
Market Cap | $14.65B | $1.30B |
Sector | Technology | Health |
52-Week High | $126.69 | $11.19 |
52-Week Low | $85.84 | $6.22 |
Enterprise Value | $13.00B | $800.50M |
Dividend Yield | 1.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
